InvestorsHub Logo
Followers 7
Posts 871
Boards Moderated 0
Alias Born 07/08/2013

Re: None

Wednesday, 04/08/2020 4:31:33 PM

Wednesday, April 08, 2020 4:31:33 PM

Post# of 73575
The next positive news was to my understanding going to be an “attorney letter” to the OTC or the SEC and then we were hoping to attain an OTC website status level of “current.” When that happens, then we were looking to see the yield sign removed.

What sort of timeframe do we expect all this to entail? What would the attorney letter swear to specifically to be true? Would an attorney refuse to write a letter for Dr. Otiko?

Is VDRM still be at risk at this time of getting shut down by the SEC for noncompliance issues or fraud. Another status change is perhaps being moved to a grey market exchange?

Thanks in advance for any insight here.

If the publicly stated intentions for the new products are true I have an intuition that there is indeed a market for it. A market that is bigger than the market for Vitastem alone. The new ones are Elixer, Prolayed, and the topical pain medication. Are there any others?